头颈部颅底肿瘤质子治疗后脑影像学改变的模式与结局
本研究回顾性分析了127例接受质子治疗的颅底头颈癌患者治疗后至少6个月的脑MRI,评估放射性影像学改变(RAIC)。17.3%的患者出现RAIC,均为无症状,3年发生率为14.3%。剂量-体积分析显示当脑V67 Gy(RBE)≥0.17 cc时RAIC发生率达63%,提示应尽量减少脑部局灶高剂量。
要点
- 质子治疗后17.3%患者出现无症状性脑RAIC,3年发生率为14.3%。
- RAIC多见于颞叶、额叶和小脑,中位最大体积仅0.5 cc。
- 脑V67 Gy(RBE)≥0.17 cc时RAIC发生率高达63%,应限制局灶高剂量。
核心结论
- 质子治疗后小灶性RAIC发生率为17.3%,多数见于鼻咽癌或鼻窦癌患者。
- 剂量-体积相关性证实,在可实现时应尽量减少脑部局灶高剂量。
研究设计与样本
- 回顾性分析127例接受质子治疗的颅底头颈癌患者,所有患者脑部至少接受40 Gy(RBE)点剂量。
- 对治疗后≥6个月的MRI进行刚性配准至计划CT,在T1增强和T2序列上勾画RAIC病灶并提取剂量-体积参数。
- 采用多状态生存分析计算RAIC概率,Cox回归进行单因素/多因素分析,递归分割分析探讨剂量-体积相关因素。
主要发现
- 17.3%的患者发生RAIC,所有事件均为无症状,位于颞叶(14例)、额叶(6例)和小脑(2例)。
- 增强RAIC病灶最大时的中位体积为0.5 cc。
- 45.5%的患者RAIC消退或改善,36.4%稳定或进展。
- 3年实际RAIC发生率为14.3%。
- 当脑V67 Gy(RBE)≥0.17 cc时,63%的患者观察到RAIC。
关键数值与推荐
- 脑V67 Gy(RBE)≥0.17 cc时RAIC发生率为63%。
- 3年RAIC实际发生率为14.3%。
- 所有患者脑部至少接受40 Gy(RBE)点剂量。
临床怎么用
- 质子治疗颅底头颈癌后应定期复查脑MRI以监测无症状性RAIC。
- 制定质子治疗计划时,应尽量将脑部V67 Gy(RBE)控制在0.17 cc以下以减少RAIC风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: To characterize patterns and outcomes of brain MR image changes after proton therapy (PT) for skull base head and neck cancer (HNC). MATERIAL AND METHODS: Post-treatment MRIs ≥6 months were reviewed for radiation-associated image changes (RAIC) in 127 patients. All patients had received at least a point dose of 40 Gy(RBE) to the brain. The MRIs were rigidly registered to planning CTs and RAIC lesions were contoured both on T1 weighted (post-contrast) and T2 weighted sequences, and dose-volume parameters extracted. Probability of RAIC was calculated using multistate survival analysis. Univariate/multivariate analyses were performed using Cox Regression. Recursive partitioning analysis was used to investigate dose-volume correlates of RAIC development. RESULTS: 17.3% developed RAIC. All RAIC events were asymptomatic and occurred in the temporal lobe (14), frontal lobe (6) and cerebellum (2). The median volume of the contrast enhanced RAIC lesion was 0.5 cc at their maximum size. The RAIC resolved or improved in 45.5% of the patients and were stable or progressed in 36.4%. The 3-year actuarial rate of developing RAIC was 14.3%. RAIC was observed in 63% of patients when V67 Gy(RBE) of the brain ≥0.17 cc. CONCLUSION: Small RAIC lesions after PT occurred in 17.3% of the patients; the majority in nasopharyngeal or sinonasal cancer. The estimated dose-volume correlations confirm the importance of minimizing focal high doses to brain when achievable.
引用
- Engeseth GM, Stieb S, Mohamed ASR, et al. Outcomes and patterns of radiation associated brain image changes after proton therapy for head and neck skull base cancers. Radiother Oncol. 2020. PMID: 32679304. doi:10.1016/j.radonc.2020.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。